有样本，需要委托检测
带上研究问题、样本类型、数量与分组，讨论靶标检测和项目评估。
了解SIMOA服务沟通检测项目SIMOA / ASSAY
p-Tau 217 (Simoa® ALZpath) Assay
For researchers in the field of neurology, detecting phosphorylated Tau 217 (p-Tau 217) in plasma or cerebrospinal fluid (CSF) is crucial in advancing studies from discovery to clinical applications. The Quanterix Simoa® ALZpath p-Tau 217 Assay offers an ultrasensitive, reliable solution to measure…
查看完整产品简介
询价 (Tel. 15750729215)
Simoa® ALZpath p-Tau 217 Assay
For researchers in the field of neurology, detecting phosphorylated Tau 217 (p-Tau 217) in plasma or cerebrospinal fluid (CSF) is crucial in advancing studies from discovery to clinical applications. The Quanterix Simoa® ALZpath p-Tau 217 Assay offers an ultrasensitive, reliable solution to measure p-Tau 217 levels, providing insights into neurodegenerative diseases like Alzheimer’s.
01 / DESCRIPTION
产品说明
p-Tau 217: A Key Biomarker in Alzheimer’s Disease
Threonine 217 is one of the critical phosphorylation sites in tau, making p-Tau 217 a significant biomarker for Alzheimer’s disease. Research shows that p-Tau 217 levels in cerebrospinal fluid (CSF) and blood are significantly elevated in patients with Alzheimer’s, even in the early stages, indicating its potential as a valuable diagnostic and prognostic tool. Furthermore, studies have shown that p-Tau 217 can help differentiate Alzheimer’s disease from other forms of dementia, such as Lewy body dementia and frontotemporal dementia.
Applications and Intended Use
The Quanterix Simoa® ALZpath p-Tau 217 assay is validated for use in discovery and diagnostic research applications. The Simoa® ALZpath p-Tau 217 assay targets the proline-rich region of the Tau protein, which is highly conserved amongst the tau isoforms.
- Research on Neurodegenerative Diseases: By measuring phosphorylated tau protein levels in the blood, researchers can gain insights into the role of p-Tau 217 in the disease process and develop new diagnostics and neuro-prognostics for these debilitating diseases.
- Drug Discovery: Identify and screen promising drug candidates for further development and testing.
- Biomarker Discovery and Validation: Researchers can use the Simoa® ALZpath p-Tau 217 assay to validate emerging biomarkers, providing researchers with a reliable and accurate tool for biomarker discovery workflows.
Compatible Instruments
The ALZpath p-Tau 217 assay is available for use on the Quanterix HD-X™ Automated Immunoassay Analyzer and SR-X™ Biomarker Detection System.
Simoa® ALZpath p-Tau-217 Advantage PLUS Assay Performance (HD-X)
Analytical LLOQ: 0.00326 pg/mL
Functional LLOQ: 0.00978 pg/mL
Functional ULOQ: 30 pg/mL
LOD: 0.0008 pg/mL; range 0.0003-0.0021 pg/mL
Dynamic Range: 0-30 pg/mL
Tests per kit: 96
Simoa® ALZpath p-Tau-217 Advantage PLUS Assay Performance (SR-X)
Functional LLOQ: 0.0129 pg/mL
LOD: 0.0004 pg/mL
Kit Contents
The assay kit includes all necessary reagents and controls to perform 96 tests, making it easy to use and compatible with various sample types.
Related Information
02 / DOCUMENTATION
资料下载
保留原有原厂资料入口。不同仪器与版本的参数，请逐一核对对应文件。
03 / CITATIONS
文献与引用
通过 Bioz 查看这款产品的引用文献、应用摘要与研究图片。
Bioz 实时文献组件 · 可在组件内筛选和滚动浏览；无法载入时可在 Bioz 打开。
Powered by Bioz
NEXT STEP / 两条实验路径
您想从哪一步开始？
有实验平台，需要试剂与方案
说明现有仪器、目标标记和实验条件，确认试剂、资料与适配范围。
浏览完整 Assay 目录咨询试剂与实验配置